Rise in Telemedicine Tied to Modest Decrease in Low-Value, Point-of-Care Testing
By Lori Solomon HealthDay Reporter
TUESDAY, March 4, 2025 -- Telemedicine adoption is associated with modestly lower use of low-value, point-of-care testing among Medicare beneficiaries, according to a study published online Feb. 24 in JAMA Internal Medicine.
Ishani Ganguli, M.D., from Harvard Medical School and Brigham and Women's Hospital in Boston, and colleagues sought to quantify the association between telemedicine adoption and low-value testing among fee-for-service Medicare beneficiaries. Beneficiary-level linear regression in a difference-in-differences (DiD) analysis included a sample of 1.38 million Medicare beneficiaries who were attributed to high-telemedicine systems and 999,051 beneficiaries who were attributed to low-telemedicine systems.
The researchers found that from 2019 to 2022, those in high-telemedicine systems had a small differential rise in visits (DiD visits per beneficiary, 0.12) and differential decreases in the use of seven of 20 low-value tests (mostly point of care): cervical cancer screening (DiD, −0.45 percentage points [pp]), screening electrocardiograms (DiD, −1.30 pp), screening metabolic panels (DiD, −1.84 pp), preoperative complete blood cell counts (DiD, −0.64 pp), preoperative metabolic panels (DiD, −1.35 pp), total or free triiodothyronine level testing for hypothyroidism (DiD, −0.90 pp), and imaging for uncomplicated low back pain (DiD, −1.66 pp). Additionally, patients in high-telemedicine systems saw statistically significant differential decreases in spending on visits per beneficiary (−$47.87) and on two of 20 low-value tests, although there were no differences in low-value spending overall.
"Results suggest possible benefits of telemedicine and mitigate concerns about telemedicine contributing to increased spending," the authors write.
Two authors disclosed ties to the health care and technology industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Swept-Source Anterior Segment OCT Can Help Distinguish Early Childhood Glaucoma
FRIDAY, May 23, 2025 -- The noninvasive swept-source anterior-segment optical coherence tomography (SS-ASOCT) can diagnose early-onset childhood glaucoma, according to a study...
Semaglutide Plus Intensive Behavioral Therapy Most Beneficial for Weight Loss
FRIDAY, May 23, 2025 -- Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in...
Higher Social Media Use Tied to Subsequent Depressive Symptoms in Youth
FRIDAY, May 23, 2025 -- Higher social media use is associated with greater subsequent depressive symptoms in children and adolescents, according to a study published online May 21...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.